Optimizing storage and scaling up of organoids
Zenit Science, a company based in Trondheim, has received 10 million NOK in funding for its innovative project focused on the development of organoids. These mini-organs, created from human cells in 3D, have the potential to replace animal testing in important research areas such as disease modeling and the testing of drugs, chemicals, and gene therapy.
The company was established by CRESCO group leader and professor at NTNU, Magnar Bjørås. The company’s research addresses the challenges of long-term storage and scaling up organoids, which will be crucial for optimizing the use of these models in medical research. The results from this project are expected to have a significant impact on the development of new diagnostic tools as well as treatments for various human diseases.